Craft

Axonics

Stock Price

$70.2

2024-10-29

Market Capitalization

$3.6 B

2024-10-29

Revenue

$366.4 M

FY, 2023

Axonics Summary

Company Summary

Overview
Axonics Modulation Technologies is a medical device company developing a neuromodulation platform based on miniaturized rechargeable technology directed toward a number of clinical indications, including the treatment of chronic pain and overactive bladder. The Axonics Sacral Neuromodulation System is a CE-marked rechargeable SNM system designed to improve the experience of both clinicians and patients suffering from urinary and fecal dysfunction.
Type
Public
Status
Active
Founded
2013
HQ
Irvine, CA, US | view all locations
Website
https://www.axonics.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Erik Amble

    Erik Amble, Director

    • Guangqiang Jiang

      Guangqiang Jiang, Chief Technology Officer

    • Juliet Tammenoms Bakker

      Juliet Tammenoms Bakker, Director

      • Rinda Sama

        Rinda Sama, Chief Operating Officer

        Operating MetricsView all

        Patent Applications

        76

        Q3, 2018

        Patients Reached

        180

        Q3, 2018

        Patents Issued

        37

        Q3, 2018

        LocationsView all

        1 location detected

        • Irvine, CA HQ

          United States

          26 Technology Dr

        Axonics Financials

        Summary Financials

        Revenue (Q3, 2024)
        $116.2M
        Gross profit (Q3, 2024)
        $89.7M
        Net income (Q3, 2024)
        ($21.0K)
        Cash (Q3, 2024)
        $239.5M
        EBIT (Q3, 2024)
        ($6.3M)
        Enterprise value
        $3.4B

        Footer menu